Helus
Business Services · United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.helus.comRevenue
$14.8 MillionIndustry
About Helus
Helus Org Chart
Is Helus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Helus is spiking on competitors!
Earning: See what the market has to say on Helus recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Helus had a recent Job posting/layoffs
Product Launch: Get notified when Helus launches new products
Congratulate Masked Content for being promoted to Masked Content at Helus
Check if Helus has recently received funding, and reach out quickly before it becomes old news!
Helus, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Helus has new funding data
Recommended Actions
Reach out to Masked Content who joined Helus as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Helus is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Helus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Helus.
Helus Tech Stack
A closer look at the technologies used by Helus
Most Recent Scoops
Helus News & Media
Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York
NEW YORK and TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, taking place June 2-4, 2026.CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
NEW YORK & TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs. The corrected release follows:Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
NEW YORK and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will be speaking at the 29th Annual Milken Institute Global Conference on a panel entitled “The Next Wave of Health Innovation.” The Conference will take place May 3-6, 2026, at The BeverlyHelus Pharma Partners with TARA Mind to Advance Veteran Mental Health
NEW YORK & TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced a collaboration with TARA Mind, which works with Veterans Exploring Treatment Solutions (“VETS”) to support clinical trial recruitment for its PARADIGM HLP003 Phase 3 program for Major Depressive Disorder (“MDD”), while expanding mental health awareness and a
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Helus
Helus Inc is a company that operates in the Research & Development industry. It employs 50to99 people and has 10Mto25M of revenue. The company is headquartered in the United States.... Read More



